Clinical algorithms

Because sickle cell disease is

blue picto innovhem research company focused on improving health of sickle cell patients

A disease with a high variability of symptoms

blue picto innovhem research company focused on improving health of sickle cell patients

Associated with premature and sudden death

Why develop a predictive algorithm ?

The development of predictive tools will provide a new paradigm of medical care by moving from a reactive to a personnalised preventive medicine in order to avoid severe manifestations.

Why predict painful crises ?

Because painful crises are the most common manifestation of SCD. Because they are reponsible for more than 50% of deaths.
Because they have a major impact on patient quality of life. Because they have a major impact on healthcare systems.
Because there are existing treatments to avoid painful crises.
vocpredict algorithm innovhem biotech research sickle cell disease

VocPredict

THE UNIQUE PREDICTIVE SOLUTION FOR PAINFUL CRISES

Developed with machine learning and combining INNOVHEM’s biomarkers with standard of care biomakers.

HOW IT WORKS ?

Using biomarkers from a blood sampling during the routine clinical follow-up, the clinical algorithm will provide a score to stratify patients according to their risk of experiencing a painful crisis in the subsequent year. Then, it will guide the physicians to propose a personalised preventive medicine in order to avoid painful crises.

Integration into clinical routine

Medical follow-up
Prescription

3

Blood sampling and clinical exams

3

Standard-of-care and INNOVHEM’s biomakers

3

Algorithm analysis

3

Clinical score

VocPredict

Patient stratification

LOW RISK

HIGH RISK

Physicians actions

MAINTAIN

blue picto innovhem research company focused on improving health of sickle cell patients

Current medical continuation

THERAPEUTIC REINFORCEMENT

blue picto innovhem research company focused on improving health of sickle cell patients

Dose escalation

blue picto innovhem research company focused on improving health of sickle cell patients

Use of expensive treatments

blue picto innovhem research company focused on improving health of sickle cell patients

Combination of treatments

Patient stratification

LOW RISK

Physicians actions

MAINTAIN

blue picto innovhem research company focused on improving health of sickle cell patients

Current medical continuation

Patient stratification

HIGH RISK

Physicians actions

THERAPEUTIC REINFORCEMENT

blue picto innovhem research company focused on improving health of sickle cell patients

Dose escalation

blue picto innovhem research company focused on improving health of sickle cell patients

Use of expensive treatments

blue picto innovhem research company focused on improving health of sickle cell patients

Combination of treatments

Key advantages

Want to know more about our clinical algorithm?

predict to avoid innovations clinical algorithms innovhem sickle cell disease

IMPROVE HEALTH OF PATIENTS

predict to avoid innovations clinical algorithms innovhem sickle cell disease

IMPROVE THE EFFICIENCY OF HEALTH CARE SYSTEMS

advantages scoring innovhem biotech research sickle cell disease

IMPROVE COST EFFECTIVENESS AND CLINICAL UTILITY

Want to know more
about VocPredict ?